Our ramped-up random testing of asymptomatic students went well this week, and we are processing the results. We tested more than 1,200 students and some faculty and staff. Next week, we begin saliva testing and will test even more community members. The testing method, called SalivaDirect, was developed by researchers at the Yale School of Public Health. It was granted an emergency use authorization by the U.S. Food and Drug Administration and has been used to test asymptomatic players and staff in the NBA. We are one of the first education institutions to use this test—if not the very first.